Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) - Analysts at HC Wainwright issued their FY2029 earnings per share estimates for shares of Delcath Systems in a research note issued to investors on Friday, March 7th. HC Wainwright analyst S. Ramakanth anticipates that the company will post earnings of $1.58 per share for the year. HC Wainwright currently has a "Buy" rating and a $24.00 target price on the stock. The consensus estimate for Delcath Systems' current full-year earnings is ($0.79) per share.
Separately, Craig Hallum upped their price objective on Delcath Systems from $18.00 to $21.00 and gave the company a "buy" rating in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $22.75.
View Our Latest Stock Report on Delcath Systems
Delcath Systems Stock Performance
Shares of Delcath Systems stock traded down $0.15 during trading hours on Monday, reaching $12.06. The company's stock had a trading volume of 191,265 shares, compared to its average volume of 330,877. Delcath Systems has a one year low of $3.70 and a one year high of $16.97. The stock's fifty day simple moving average is $14.42 and its two-hundred day simple moving average is $11.78. The company has a market capitalization of $385.48 million, a P/E ratio of -8.93 and a beta of 0.82.
Delcath Systems (NASDAQ:DCTH - Get Free Report) last issued its earnings results on Thursday, March 6th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). The business had revenue of $15.10 million for the quarter, compared to analyst estimates of $14.96 million. Delcath Systems had a negative return on equity of 338.16% and a negative net margin of 150.70%. During the same period in the previous year, the firm posted ($0.48) EPS.
Hedge Funds Weigh In On Delcath Systems
A number of institutional investors and hedge funds have recently made changes to their positions in DCTH. Principal Financial Group Inc. bought a new stake in shares of Delcath Systems in the 3rd quarter valued at about $808,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Delcath Systems during the third quarter valued at approximately $102,000. Polar Asset Management Partners Inc. purchased a new position in Delcath Systems in the 3rd quarter worth approximately $1,594,000. State Street Corp boosted its holdings in Delcath Systems by 12.4% in the 3rd quarter. State Street Corp now owns 85,457 shares of the company's stock valued at $772,000 after purchasing an additional 9,400 shares during the last quarter. Finally, Jane Street Group LLC acquired a new stake in shares of Delcath Systems during the third quarter valued at about $110,000. 61.12% of the stock is owned by hedge funds and other institutional investors.
About Delcath Systems
(
Get Free Report)
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Read More
Before you consider Delcath Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delcath Systems wasn't on the list.
While Delcath Systems currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
